NuCana plc American Depositary Share

NCNA XNAS

Historical Short Interest Share

American Express® Business Gold Card

Earn Up to 200K Membership Rewards® Points

4X on your top 2 spending categories. Transfer to 20+ airline & hotel partners. Terms apply.

Learn More

Market Cap

8.6M

Short interest (May 15)

4.0%

Net Short (Jun 03 ): 0.0%

Borrow Fee

12.12%

↑ 2.7%

Available Shares

200K

↑ 20.0%

Price Chart

Company Overview

NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States and the United Kingdom.

Company Info

Exchange: NASDAQ

CIK: 0001709626

Asset Type: ADRC

Market Data

Market Cap: $8,615,279

Employees: 12

Status: Active

Short Interest

Current Borrow Fee 12.12%

Range: 11.95% - 12.12%

Available Shares 200K

Range: 100K - 150K

Recent Changes

Fee Change: ↑ 7.9%

Available Change: ↑ 20.0%

Quick Actions

View Dilution Chart

Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam • Unsubscribe anytime